Anti-IL-13Ra2 / CD213a2
Product Specifications
Target
IL Receptor
Applications
Immunology & Inflammation
Additionnal Information
Anti-IL-13Ra2 / CD213a2 is a humanized monoclonal antibody targeting IL-13Ra2. It exhibits potentcy against malignant gliomas (MG), head and neck tumors, ovarian cancer and kidney cancer. MW :150 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400253-500 1x 500 µL
Cytokeratin, LMW (AE-1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880525-100 1x 100 µL
CD63 (MX-49.129.5), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740266-100 1x 100 µL
Human IgG Immunoglobulin (IG266), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740414-500 1x 500 µL
Chromogranin A (CGA/414), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470748-100 1x 100 µL
CD5 (C5/473 + CD5/54/F6), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041022-100 1x 100 µL
Hepatocyte Specific (CPS1/1022), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details